BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abouelasrar Salama S, Lavie M, De Buck M, Van Damme J, Struyf S. Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection. Cytokine Growth Factor Rev 2019;50:29-42. [PMID: 31718982 DOI: 10.1016/j.cytogfr.2019.10.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Yoon T, Ahn SS, Yoo J, Song JJ, Park YB, Lee SW. Serum Amyloid A Is a Biomarker of Disease Activity and Health-Related Quality-of-Life in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Dis Markers 2020;2020:8847306. [PMID: 33488845 DOI: 10.1155/2020/8847306] [Reference Citation Analysis]
2 Federico S, Pozzetti L, Papa A, Carullo G, Gemma S, Butini S, Campiani G, Relitti N. Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists. J Med Chem 2020;63:13466-513. [PMID: 32845153 DOI: 10.1021/acs.jmedchem.0c01049] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
3 Liu Q, Dai Y, Feng M, Wang X, Liang W, Yang F. Associations between serum amyloid A, interleukin-6, and COVID-19: A cross-sectional study. J Clin Lab Anal 2020;34:e23527. [PMID: 32860278 DOI: 10.1002/jcla.23527] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
4 Su X, Zhao X, Deng JL, Li SN, Du X, Dong JZ, Ma CS. Antiviral treatment for hepatitis C is associated with a reduced risk of atherosclerotic cardiovascular outcomes: A systematic review and meta-analysis. J Viral Hepat 2021;28:664-71. [PMID: 33452699 DOI: 10.1111/jvh.13469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fatone MC. COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations? Curr Rheumatol Rev 2021;17:7-16. [PMID: 33019935 DOI: 10.2174/1573397116666201005122603] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Al‐saffar OB, Ad'hiah AH. Genetic variants in IL4RA , IL6 , and IL12B genes and susceptibility to hepatitis B and C virus infections among Iraqi patients. J Med Virol 2020;92:3448-58. [DOI: 10.1002/jmv.26297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Ciregia F, Nys G, Cobraiville G, Badot V, Di Romana S, Sidiras P, Sokolova T, Durez P, Fillet M, Malaise MG, de Seny D. A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis. Front Immunol 2021;12:638814. [PMID: 34489924 DOI: 10.3389/fimmu.2021.638814] [Reference Citation Analysis]
8 Zou S, Liu J, Yang Z, Xiao D, Cao D. SAA and CRP are potential indicators in distinction and severity assessment for children with influenza. Int J Infect Dis 2021;108:357-62. [PMID: 34052408 DOI: 10.1016/j.ijid.2021.05.057] [Reference Citation Analysis]
9 Gursky O. Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve. Curr Atheroscler Rep 2020;22:69. [PMID: 32968930 DOI: 10.1007/s11883-020-00888-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
10 Lee CH. Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm. Arch Pharm Res 2021;44:84-98. [PMID: 33398691 DOI: 10.1007/s12272-020-01299-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Turmagambetova AS, Alexyuk MS, Bogoyavlenskiy AP, Alexyuk PG, Zaitseva IA, Omirtaeva ES, Sokolova NS, Berezin VE. Effect of the nanocapsulated adjuvant Sapomax on the expression of some immune response genes. Arch Virol 2020;165:1445-51. [PMID: 32248293 DOI: 10.1007/s00705-020-04619-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Abouelasrar Salama S, Gouwy M, Van Damme J, Struyf S. The turning away of serum amyloid A biological activities and receptor usage. Immunology 2021;163:115-27. [PMID: 33315264 DOI: 10.1111/imm.13295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]